Tumor necrosis factor p55 receptor (TNF-RI) mediates the in vitro inhibition of hepatic erythropoietin production
Tumor necrosis factor p55 receptor (TNF-RI) mediates the in vitro inhibition of hepatic erythropoietin production
复制标题
DOI:
10.1016/s0301-472x(98)00054-x
复制
发表时间:
1999-02-01
影响因子:
2.6
通讯作者:
Hellwig-Buergel, T
中科院分区:
文献类型:
--
作者:
Jelkmann, W;Hellwig-Buergel, T
Tumor necrosis factor alpha (TNF alpha) is thought to contribute to the blunted erythropoietin (Epo) production in inflammatory diseases, The present study was carried out to find out as to whether the 55 kD (TNF-RI) or the 75 kD (TNF-RU) receptor is responsible for the TNF alpha-induced inhibition of hepatic Epo synthesis. When the effects of two receptor-specific mutants were compared, only the TNF-RI-specific isoform proved to suppress the formation of immunoreactive Epo in the human hepatoma cell lines HepG2 and Hep3B, similar to the effect of wild-type TNF alpha. Anti-TNF alpha antibody restored Epo production in TNF alpha- or TNF-RI mutant-treated cultures, By gel shift assay NF-kappa B binding to DNA was demonstrated following the addition of TNF alpha or TNF-RI-specific mutant to HepG2 cells, while the TNF-RII-specific mutant was ineffective. Finally, immunoreactive TNF-RI, but not TNF-RII, fragments were measurable in cell culture supernatants. Taken together, these results suggest that the inhibition of hepatic Epo production by TNF alpha is mediated by TNF-RI signaling. (C) 1999 International Society for Experimental Hematology, Published by Elsevier Science Inc.